The issue of the correct use of probiotics in the absence of recommendations
References
- Adams M.R., Marteau P.: On the safety of lactic acid bacteria from food. Int. J. Food Microbiol., 1995; 27: 263–264
- Azad A.K., Sarker M., Li T., Yin J.: Probiotic species in the modulation of gut microbiota: An overview. Biomed. Res. Int., 2018; 2018: 9478630
- Bartnicka A., Szachta P., Gałęcka M.: Faecal microbiota transplant – prospects and safety. Pomeranian J. Life Sci., 2015; 61: 282–286
- Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., Nieuwenhuijs V.B., Bollen T.L., van Ramshorst B., Witteman B.J., Rosman C., Ploeg R.J., Brink M.A., Schaapherder A.F., Dejong C.H., et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet, 2008; 371: 651–659
- Binek M.: Mikrobiom człowieka – zdrowie i choroba. Post. Mikrobiol., 2012; 51: 27–36
- Bischoff S.C., Escher J., Hébuterne X., Kłęk S., Krznaric Z., Schneider S., Shamir R., Stardelova K., Wierdsma N., Wiskin A.E., Forbes A.: ESPEN practical guideline: Clinical nutrition in inflammatory bowel disease. Clin. Nutrition, 2020; 39: 632–653
- Brown W.R.: Fecal microbiota transplantation in treating Clostridium difficile infection. J. Dig. Dis., 2014; 15: 405–408
- Charteris W.P., Kelly P.M., Morelli L., Collins J.K.: Antibiotic susceptibility of potentially probiotic Lactobacillus species. J. Food Prot., 1998; 61: 1636–1643
- Cichy W., Gałęcka M., Szachta P.: Probiotyki jako alternatywne rozwiązanie i wsparcie terapii tradycyjnych. Zakażenia, 2010; 6: 2–8
- Cremon C., Barbaro M.R., Ventura M., Barbara G.: Pre- and probiotic overview. Curr. Opin. Pharmacol., 2018; 43: 87–92
- Curragh H.J., Collins M.A.: High levels of spontaneous drug resistance in Lactobacillus. J. Appl. Bacteriol., 1992; 73: 31–36
- Dopuszczanie do obrotu suplementów diety. Najwyższa Izba Kontroli. https//www.nik.gov.pl/plik/id.13031,vp,15443.pdf. (18.12.2019)
- Doron S., Snydman D.R.: Risk and safety of probiotics. Clin. Infect. Dis., 2015; 60, Suppl. 2: 129–134
- Fenster K., Freeburg B., Hollard C., Wong C., RønhaveLaursen R., Ouwehand A.C.: The production and delivery of probiotics: A review of a practical approach. Microorganisms, 2019; 7: 83
- Floch M.H., Walker W.A., Guandalini S., Hibberd P., Gorbach S., Surawicz C., Sanders M.E., Garcia-Tsao G., Quigley E.M.M., Isolauri E., Fedorak R.N., Dieleman L.A.: Recommendations for probiotic use – 2008. J. Clin. Gastroenterol., 2008; 42, Suppl. 2: 104–108
- Floch M.H., Walker W.A., Sanders M.E., Nieuwdorp M., Kim A.S., Brenner D.A., Qamar A.A., Miloh T.A., Guarino A., Guslandi M., Dieleman L.A., Ringel Y., Quigley E.M., Brandt L.J.: Recommendations for probiotic use – 2015 update: Proceedings and consensus opinion. J. Clin. Gastroenterol., 2015; 49, Suppl. 1: 69–73
- Francino M.P.: Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front. Microbiol., 2016; 6: 1543
- Fric P.: Probiotics and prebiotics – renaissance of a therapeutic principle. Open Med., 2007; 2: 237–270
- Gibson G.R., Rastall R.A., Roberfroid M.B.: Prebiotics. In: Colonic Microbiota, Nutrition and Health. ed.: G.R. Gibson, M.B. Roberfroid. Springer Netherlands, Dordrecht 1999, 101–124
- Główny Inspektorat Sanitarny – Gov.pl. https//www.gis.gov.pl/o-nas/aktualności/480-suplementy-kontrola-nik-i-uwagi-gis (20.01.2020)
- Gomes D.O., de Morais M.B.: Gut microbiota and the use of probiotics in constipation in children and adolescents: systematic review. Rev. Paul. Pediatr., 2019; 38: e2018123
- Guarino A., Ashkenazi S., Gendrel D., Lo Vecchio A., Shamir R., Szajewska H., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, European Society for Pediatric Infectious Diseases: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J. Pediatr. Gastroenterol. Nutr., 2014; 59: 132–152
- Guidelines for the Evaluation of Probiotics in Food. Joint FAO/WHO Working Group Report on Draging Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002 (20.11.2019)
- Hamilton-Miller J.M., Shah S., Winkler J.T.: Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr., 1999; 2: 223–229
- Hoa N.T., Baccigalupi L., Huxham A., Smertenko A., Van P.H., Ammendola S., Ricca E., Cutting A.S.: Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl. Environ. Microbiol., 2000; 66: 5241–5247
- Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K.: Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol., 2011; 19: 349–359
- Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis in’t Veld J.H.: Overview of gut flora and probiotics. Int. J. Food Microbiol., 1998; 41: 85–101
- Jach M., Łoś R., Maj M., Malm A.: Probiotyki – aspekty funkcjonalne i technologiczne. Post. Mikrobiol., 2013; 52: 161–170
- Jernberg C., Löfmark S., Edlund C., Jansson J.K.: Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J, 2007; 1: 56–66
- Kamińska E.: Skuteczność i bezpieczeństwo stosowania probiotyków na podstawie badań klinicznych przeprowadzonych u dzieci. Med. Wieku Rozwoj., 2012; 16: 240–251
- Kaźmierska A.: Probiotyki – recepta na zdrowie? Kosmos, 2014; 63: 455–472
- Kim H.J., Vazquez Roque M.I., Camilleri M., Stephens D., Burton D.D., Baxter K., Thomforde G., Zinsmeister A.R.: A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol. Motil., 2005; 17: 687–696
- Kothari D., Patel S., Kim S.K.: Probiotic supplements might not be universally-effective and safe: A review. Biomed. Pharmacother., 2019; 111: 537–547
- Krasnowska Y., Sikora T.: Suplementy diety a bezpieczeństwo konsumenta. Żywn. Nauka Technol. Jakość, 2011; 77: 5–23
- Kubiszewska I., Januszewska M., Rybka J., Gackowska L.: Bakterie kwasu mlekowego i zdrowie: czy probiotyki są bezpieczne dla człowieka? Postępy Hig. Med. Dośw., 2014; 68: 1325–1334
- Kuśmierska A., Fol M.: Właściwości immunomodulacyjne i terapeutyczne drobnoustrojów probiotycznych. Probl. Hig. Epidemiol, 2014; 95: 529–540
- La Fata G., Weber P., Mohajeri M.H.: Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob. Proteins, 2018; 10: 11–21
- Lloyd-Price J., Abu-Ali G., Huttenhower C.: The healthy human microbiome. Genome Med, 2016; 8: 51
- Löfmark S., Jernberg C., Jansson J.K., Edlund C.: Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J. Antimicrob. Chemother., 2006; 58: 1160–1167
- López-Moreno A., Aguilera M.: Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosis. Nutrients, 2020; 12: 757
- Lutyńska A., Augustynowicz E., Wiatrzyk A.: Problemy stosowania suplementów diety zawierających probiotyki. Probl. Hig. Epidemiol., 2012; 93: 493–498
- Malla M.A., Dubey A., Kumar A., Yadav S., Hashem A., Abd Allah E.F.: Exploring the human microbiome: The potential future role of next–generation sequencing in disease diagnosis and treatment. Front. Immunol., 2019; 9: 2868
- Manzanares W., Lemieux M., Langlois P.L., Wischmeyer P.E.: Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care, 2016; 19: 262
- Marcinkiewicz J., Ciszek M., Bobek M., Strus M., Heczko P.B., Kurnyta M., Biedroń R., Chmielarczyk A.: Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol., 2007; 88: 155–164
- McDonald D., Ackermann G., Khailova L., Baird C., Heyland D., Kozar R., Lemieux M., Derenski K., King J., Vis-Kampen C., Knight R., Wischmeyer P.E.: Extreme dysbiosis of the microbiome in critical illness. mSphere, 2016; 1: e00199–00216
- Miecznikow E.: O naturze ludzkiej. Zarys filozofii optymistycznej. Translated by F. Wermiński. Warszawa: Biblioteka Naukowa 1907
- Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R.N., Staiano A.: Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol., 2009; 104: 437–443
- Mojka K.: Probiotyki, prebiotyki i synbiotyki – charakterystyka i funkcje. Probl. Hig. Epidemiol., 2014; 95: 541–549
- Monteagudo-Mera A., Rastall R.A., Gibson G.R., Charalampopoulos D., Chatzifragkou A.: Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol., 2019; 103: 6463–6472
- Mundula T., Ricci F., Barbetta B., Baccini M., Amedei A.: Effect of probiotics on oral candidiasis: A systematic review and meta-analysis. Nutrients, 2019; 11: 2449
- Najwyższa Izba Kontroli. https://www.nik.gov.pl/aktualnosci/nik-o-dopuszczaniu-do-obrotu-suplementow-diety.html (27.4.2020)
- Natural Health Products Ingredients Database. https://www.webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_probiotics_english.pdf. (15.01.2020)
- Nowak A., Śliżewska K., Libudzisz Z: Probiotyki – historia i mechanizmy działania. Żywn. Nauka Technol. Jakość, 2010; 4: 5–19
- Olszewska J., Jagusztyn-Krynicka E.K.: Human Microbiome Project – mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowieka. Post. Mikrobiol., 2012; 51: 243–256
- O’Toole P.W., Marchesi J.R., Hill C.: Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol., 2017; 2: 17057
- Ouwehand A.C.: A review of dose-responses of probiotics in human studies. Benef. Microbes, 2017; 8: 143–151
- Panasiuk A: Mikrobiota przewodu pokarmowego. Wydawnictwo Lekarskie PZWL, Warszawa 2019
- Pattani R., Palda V.A., Hwang S.W., Shah P.S.: Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: Systematic review and meta-analysis. Open Med., 2013; 7: 56–67
- Renter G.: Present and future of probiotics in Germany and in Central Europe. Biosci. Microflora, 1997; 16: 43–51
- Rudzki L., Szulc A.: Wpływ jelitowej flory bakteryjnej na ośrodkowy układ nerwowy i jej potencjalne znaczenie w leczeniu zaburzeń psychicznych. Farmakoter. Psych. Neurol., 2013; 2: 69–77
- Ruszkowski J., Szewczyk A., Witkowski J.M.: An overview of oral prebiotics, probiotics, synbiotics and post-biotic available on the Polish pharmacy market. Farm. Pol., 2018; 74: 114–122
- Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Fondén R., Saxelin M., Collins K., Mogensen G., Birkeland S.E., Mattila-Sandholm T.: Demonstration of safety of probiotics – a review. Int. J. Food Microbiol., 1998; 44: 93–106
- Saxelin M., Lassig A., Karjalainen H., Tynkkynen S., Surakka A., Vapaatalo H., Järvenpää S., Korpela R., Mutanen M., Hatakka K.: Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int. J. Food Microbiol., 2010; 144: 293–300
- Schrezenmeir J., de Vrese M.: Probiotics, prebiotics, and synbiotics – approaching a definition. Am. J. Clin. Nutr., 2001; 73: 361–364
- Suez J., Zmora N., Zilberman-Schapira G., Mor U., Dori-Bachash M., Bashiardes S., Zur M., Regev-Lehavi D., Ben-Zeev Brik R., Federici S., Horn M., Cohen Y., Moor A.E., Zeevi D., Korem T., et al.: Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 2018; 174: 1406–1423
- Summary of Product Characteristics (Charakterystyka Produktu Leczniczego) Enterol. https://www.pub.rejestrymedyczne.csioz.gov.pl/Pobieranie.ashx?type=7890-c (15.11.2019)
- Szachta P., Pazgrat M., Cichy W., Muszyński Z., Ignyś I.: Szczepy probiotyczne –perspektywy i bezpieczeństwo. Gastroenterol. Pol., 2009; 16: 37–41
- Szajewska H.: Praktyczne zastosowanie probiotyków. Gastroenterol. Klin., 2014; 6: 16–23
- Szajewska H.: Probiotyki w Polsce – kiedy, jakie i dlaczego? Gastroenterol. Klin., 2010; 2: 1–9
- Szajewska H.: Probiotyki w gastroenterologii – aktualny stan wiedzy. Gastroenterol. Klin., 2015; 7: 20–26
- Szajewska H., Canani R.B., Guarino A., Hojsak I., Indrio F., Kolacek S., Orel R., Shamir R., Vandenplas Y., van Goudoever J.B., Weizman Z., ESPGHAN Working Group for ProbioticsPrebiotics: Probiotics for the prevention of antibiotic-associated diarrhea in children. J. Pediatr. Gastroenterol. Nutr., 2016; 62: 495–506
- Szajewska H., Guarino A., Hojsak I., Indrio F., Kolacek S., Shamir R., Vandenplas Y., Weizman Z., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition: Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J. Pediatr. Gastroenterol. Nutr., 2014; 58: 531–539
- Szajewska H., Gyrczuk E., Horvath A.: Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J. Pediatr., 2013; 162: 257–262
- Szajewska H., Kołodziej M., Gieruszczak-Białek D., Skórka A., Ruszczyński M., Shamir R.: Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children – a 2019 update. Aliment. Pharmacol. Ther., 2019; 49: 1376–1384
- Szymański H., Chmielarczyk A., Strus M., Pejcz J., Jawień M., Kochan P., Heczko P.B.: Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children. Dig. Liver Dis., 2006; 38, Suppl. 2: 274–276
- The law on food safety and nutrition of 25 August 2006. Dz. U. 2006r. Nr 171, poz.1225; (09.12.2019)
- Tokarz-Deptuła B., Śliwa-Dominiak J., Adamiak M., Deptuła W.: Probiotyki a wybrane schorzenia u ludzi. Post. Mikrobiol., 2015; 54: 133–140
- Tompkins T.A., Mainville I., Arcand Y.: The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Benef. Microbes, 2011; 2: 295–303
- Tsai Y.L., Lin T.L., Chang C.J., Wu T.R., Lai W.F., Lu C.C., Lai H.C.: Probiotics, prebiotics and amelioration of diseases. J. Biomed. Sci., 2019; 26: 3
- Wasilewska E., Złotkowska D., Pijagin M.E.: The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer. Postępy Hig. Med. Dośw., 2013; 67: 837–847
- Whorwell P.J., Altringer L., Morel J., Bond Y., Charbonneau D., O’Mahony L., Kiely B., Shanahan F., Quigley E.M.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol., 2006; 101: 1581–1590
- World Gastroenterology Organisation Global Guidelines. Probiotics and prebiotics. https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english (27.4.2020)
- Yan F., Polk D.B.: Probiotics and immune health. Curr. Opin. Gastroenterol., 2011; 27: 496–501
- Yoon M.Y., Yoon S.S.: Disruption of the gut ecosystem by antibiotics. Yonsei Med. J., 2018; 59: 4–12
DOI: https://doi.org/10.5604/01.3001.0014.7701 | Journal eISSN: 1732-2693
Language: English
Page range: 107 - 115
Submitted on: Jan 13, 2020
Accepted on: Nov 9, 2020
Published on: Feb 25, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2021 Hanna Tomczak, Marta Wrońska, Paulina Pecyna, Katarzyna Hampelska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.